InHandPlus

The obesity pandemic is here.  Nearly 1 billion people worldwide are battling obesity, and by 2035, more than half of the global population will be overweight. The future of health is here: AI-powered technologies are revolutionizing healthcare by tracking daily habits, delivering personalized solutions, enabling real-time health monitoring, and creating smarter strategies for chronic disease management. Digital health care transforms obesity treatment from a one-size-fits-all approach to a precision, personalized journey. At InHandPlus, we are not just part of the revolution—we are leading it. Our AI-based smartwatches are designed to enhance chronic disease management, improve medication adherence, and provide continuous, real-time health monitoring for patients. Ready to be part of the healthcare transformation? Learn how AI technology is changing the obesity landscape! 👉 #InHandPlus #AI #Obesity #DigitalHealthcare #pharmaceutical

[InHandPlus at the MFDS-KSCD Annual Conference 2024]   InHandPlus is thrilled to announce its participation in the upcoming MFDS-KSCD Annual Conference, hosted by the Korean Society for Clinical Development!    The KSCD annual conference will occur on December 4 at the Dragon City Hotel in Seoul. This premier event offers an excellent opportunity for clinical trial professionals, including Clinical Research Associates (CRAs), Clinical Research Coordinators (CRCs), and Quality Assurance (QA) specialists, to explore the latest global trends and advancements in clinical research.   We’ll be showcasing our innovative AI-based smartwatch designed to enhance clinical trial processes by improving medication adherence and participation rates. Visit our booth on December 4th, from 9AM to 6PM, to discover how the InHand-Watch is revolutionizing the clinical field. Don’t miss this chance to connect with us and learn how we can advance clinical development together. For venue directions, please refer to the detailed map below. We look forward to seeing you there!   𝗕𝗼𝗼𝘁𝗵 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 Location:  Grandball room Hanra, the 3rd floor the Dragon City Hotel , Seoul Date: December 4th Wednesday, 2024 Time: 9:00~18:00 #InHandPlus #AI  #DigitalHealthcare #pharmaceuticals #KSCD #OnDeviceAI

We are excited to share our experience at TechCrunch Disrupt and a new partnership with Adherence! InHandPlus participated in TechCrunch Disrupt, North America’s largest startup exhibition, held in San Francisco from October 28 to 30. At the event, our AI-powered medication management smartwatch, "InHand-Watch," gained significant interest. On the second day, CEO Hwiwon Lee introduced the innovative technology of InHand-Watch during a live pitch session, demonstrating its value within the healthcare industry. CEO Lee also announced a partnership with Adherence, a global medication adherence solutions company led by Philip Morisky. Adherence is the exclusive provider of the Morisky Medication Adherence Scales (MMAS), a widely used tool for measuring medical adherence. Through this collaboration, InHandPlus aims to enhance patients’ convenience in medication adherence. 🔗: https://lnkd.in/gb_zg_a5 #InHandPlus #AI #DigitalHealthcare #pharmaceuticals #TechCrunchDisrupt #MedicationAdherence #Adherence #MMAS

How are emerging technologies reshaping the landscape of elderly care? We’re witnessing a revolutionary shift in supporting our aging population through groundbreaking initiatives: smart community centers, AI call services, and InHandPlus’s AI smartwatch solution. These digital innovations are redefining the future of elderly care, making it more connected, efficient, and compassionate. Curious to discover how these technological advances are creating a safer, more supportive environment for seniors? Read our comprehensive analysis of this rapidly evolving landscape! #InHandPlus #AI #DigitalHealthcare #pharmaceuticals #ElderlyCare #SeniorCare #MedicationAdherence

InHandPlus will participate in the upcoming Fall Conference of the KSCPT(Korean Society for Clinical Pharmacology and Therapeutics)! The KSCPT Fall Conference, ‘Clinical Pharmacology in Innovative Therapeutics’, will take place from November 13 to 16 at the Kimdaejung Convention Center in Gwangju. It will feature a variety of sessions on cutting-edge topics, such as ICT in Clinical Trials and early-phase trial site innovations. We invite you to visit the InHandPlus booth in the Partner Exhibition Area on the 4th floor to experience our innovative AI-based smartwatch for medical adherence. The booth will be open on November 14-15. For detailed location information, please refer to the map below. Join us to connect and explore the latest advancements in AI technology for medication management. 𝗕𝗼𝗼𝘁𝗵 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 Location: Partner Exhibition Area, 5th booth, Kimdaejung Convention Center(4th floor), Gwangju Time: November 14-15, 2024   #InHandPlus #AI #DigitalHealthcare #pharmaceuticals #KSCPT

We are excited to announce our participation in #TechCrunchDisrupt2024 ! TechCrunch Disrupt 2024 is the place to explore innovation at every stage of your startup journey. The event will occur at #MosconeWest in San Francisco from October 28 to 30, 2024. Don’t miss the opportunity to discover our innovative #AI_based_Smartwatch for medication adherence up close. You can find us at Booth C23 on the 2nd floor of Moscone West, within the Korean Pavilion(한국관). We’ve included a simplified map to help you locate our booth easily. In addition, Hwiwon Lee, CEO of #InHandPlus, will deliver a live pitch introducing our AI-powered smartwatch, #DoctoronWrist. Join us at the Pitch Showcase stage on October 28, where he will present as the 4th speaker from 3:30 PM to 4:00 PM during the second session of Day1. The presentation will offer a unique opportunity to learn how our technology can enhance medication adherence and make a positive impact on the healthcare sector. 𝗕𝗼𝗼𝘁𝗵 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 Location: Korean Pavilion (한국관) C23, The 2nd floor of the Moscone west, San Francisco, CA 94103 Time: October 28th - 30th, 2024   𝗟𝗶𝘃𝗲 𝗣𝗶𝘁𝗰𝗵 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗜𝗻𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 Location: Pitch showcase stage, The 2nd floor of the Moscone West Time: 3:30pm - 4:00pm, October 28th, 2024 (4th presenter) #InHandPlus #AI #SmartWatch #DigitalHealthcare #DoctoronWrist #OnDeviceAI #TechCrunchDisrupt2024

InHandPlus at DIA ASIA 2024 InHandPlus CEO Hwiwon Lee delivered a keynote presentation at DIA ASIA 2024, introducing an AI-powered smartwatch for personalized medication management. The event was held at the K Hotel in Seoul on September 25-26. The presentation highlighted the significant potential of wearable technology integrated with artificial intelligence (AI) to enhance medication adherence and optimize therapeutic outcomes. In addition to the keynote, InHandPlus participated as one of six exhibitors, showcasing their advancements in digital health technology. #InHandPlus #AI #SmartWatch #DigitalHealthcare #DoctoronWrist #OnDeviceAI #DIA #KRSC #Workshop #DIAASIA2024

On the 14th, InHandPlus and MEDIDATA signed an MOU. Through this MOU, we plan to link the clinical participants' medication data collected from InHandWatch to MEDIDATA's clinical platform. Researchers will be able to remotely monitor the health status of clinical participants in real-time in domestic and international clinical trials based on this. Currently, the two companies' solutions are being used in phase 2 clinical trials in the United States, and by using this, it is expected that the cost and duration of clinical trials can be reduced. #InHandPlus #AI #SmartWatch #DigitalHealthcare #DoctoronWrist #OnDeviceAI #MEDIDATA #MOU 🔗 https://lnkd.in/gs5QcKYH

The CEO of InHandPlus dreams of innovation accompanied by the socially underprivileged and believes that real innovation is to return it to everyone enjoying it without discrimination. This representative's ideology can also be confirmed in his actions, such as distributing InHand-Watch to the vulnerable in cooperation with local governments. In addition to pills, inhalers, and injections can be used to capture and record the usage patterns of various medications by InHand-Watch. It can also expand the analysis target to physical activity, as well as heart rate, oxygen saturation, body temperature, and falls. Currently, more than 300,000 scenarios have been applied to AI, and they plan to increase the learning data to 1 million cases in the future and achieve more than 99% accuracy to improve the data quality. #InHandPlus #AI #SmartWatch #DigitalHealthcare #DoctoronWrist #OnDeviceAI 🔗 https://lnkd.in/g8earQga

The AI-driven InHand-Watch, developed by InHandPlus, leverages real-world data to monitor medication adherence, addressing the critical issue of non-adherence in clinical trials. Enhancing data accuracy and reducing costs play a key role in decentralized clinical trials (DCTs). The InHand-Watch has gained global attention, with partnerships from companies like Bayer and Merck, and has demonstrated a 20% improvement in adherence. As South Korea approaches a super-aged society by 2025, the device’s comprehensive health monitoring capabilities are poised to support chronic and mental health management, particularly for the elderly. #InHandPlus #AI #SmartWatch #DigitalHealthcare #DoctoronWrist #OnDeviceAI #CES2023 #TryEverything2023 🔗 https://lnkd.in/gk_JZxtU  🔗 https://lnkd.in/gR4-4sAa